SCHEMBL3177170

SCHEMBL3177170

COc1ccc(N2CCN(C(=O)C(=O)Nc3cc(NCCNC(C)=O)nc(-c4ccccc4)n3)CC2)c(OC)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NTSR1 P30989 1/20 0.46
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ CLK4 Q9HAZ1 1/20 0.44
▸ MTNR1A P48039 2/20 0.43
▸ MTNR1B P49286 2/20 0.43
▸ SLC1A2 P43004 1/20 0.41
▸ HTR1A P08908 4/20 0.40
▸ ADORA3 P0DMS8 2/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ ADRA2A P08913 1/20 0.39
▸ DRD2 P14416 1/20 0.39
▸ DRD1 P21728 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3175820 0.92 MEN1 (0.46) NTSR1HTR1AMEN1KMT2AADRA2A
SCHEMBL3260451 0.89 SLC1A2 (0.52) NTSR1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL3156095 0.88 SLC1A2 (0.46) CYP1A2CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL3169692 0.88 ADORA3 (0.47) NTSR1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL3156223 0.84 KMT2A (0.42) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL3164424 0.84 ADORA2A (0.41) CYP1A2CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL3166495 0.84 SLC1A2 (0.44) CYP1A2CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL3170204 0.84 KMT2A (0.43) TSHRHTR1AADORA3SMN1; SMN2MEN1
SCHEMBL3156119 0.83 PHGDH (0.42) TSHRADORA3SMN1; SMN2MEN1NPC1
SCHEMBL3175769 0.83 ADORA2A (0.45) CYP1A2CYP3A4CYP2D6TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback